In March 2022, all public cannabis companies in Israel listed on the stock exchange published their complete financial statements.

The Israeli "Cannabis" magazine collected the data. It examined which of the companies developed, grew, and managed to make a profit last year and which only took a few more steps backward and may even be close to bankruptcy.

The most successful cannabis companies in IsraelIn first place: Intercure - earned 30.3 million NIS (approximately 7.25 million GBP) and has unquestionably become the leading Israeli cannabis company.For Intercure, which owns the "Canndoc" cannabis brand and the "Givol" pharmacy chain, last year was the most successful year. Intercure reported a record revenue of 219.7 million NIS, which is an increase of 238% compared to revenues of 65 million NIS in the previous year, and a profit of NIS 30.3 million, which is an increase of 168% compared to a profit of 11.3 million NIS last year.

In all the financial data and the market value figure, which stands at 965 million NIS at the time of writing, Intercure is at the top of the companies in the Israeli cannabis sector on the stock exchange. The company has made many acquisitions in the past year, including the "Parmeson" pharmacy. It has also begun sales from the Nir Oz cannabis farm, in which it has invested tens of millions of shekels. After finishing the year as a leader in the domestic market, it is looking at expanding into overseas markets, along with the American "cookies" brand.In second place: BOL Pharma - completed a turnaround from loss to profit, attack and entered into significant investments in the retail sector.

According to the results of the last two years, Pharma (formerly "Aspiration for Life") has established itself as the second-largest cannabis company in terms of profits and revenues in the cannabis sector on the stock exchange, and without a doubt, the company that underwent the most significant revolution. Suppose it were not a private company (and therefore has no market capitalization on the stock exchange.

Its information can only be found out because its essential shareholder, "Amir Marketing," is a public company). It would probably be in a high place after presenting 139 million NIS revenue, which is an increase of 72% compared to 80.8 million NIS last year when the company was under another management that led it to become the most loss-making company in Israel.

In third place: Seach Medical - earned 7.5 million NIS, jumped in revenue, and plans to expand in the pharmacy chainThe last year was also quite good for Seach, when in total, it reports revenues of about 67 million NIS, which is a jump of approximately 82.8% compared to revenues of about 36.8 million NIS last year (12.5% of the increase in revenues came from the purchase of inflorescence and gemstone pharmacies).

However, in the case of a discourse unlike its two previous ones on the list, the company presented a decrease of about 6.8% in a representative net profit of about 7.55 million NIS compared to a net profit of about 8.1 million NIS last year.

Still, Seach ended the year with excellent profitability, which places it as one of the three most profitable companies in the sector. Seach now plans to expand the pharmacy chain to about 10 pharmacies and expand in the field of exports abroad.The most failed cannabis companies in IsraelCannomed - missed the forecasts, sold the main activity to Intercure, and cannot promote the activity it has left.

The year 2021 hasn't been too kind for Cannomed. It sort of "exited" from the cannabis sector during the year when it sold its retail activity, which mainly included control (55%) in the "Bio Max Pharm" pharmacy chain and several other related activities, including patient training, in return to 16.6 million NIS. Cannomed presented revenues of 658 million NIS from its cannabis farm - the only activity it has left in the field of cannabis - a decrease of 75.6% compared to revenues of 2.7 million NIS last year, while not meeting the forecasts it set for itself in the past.

Intelicanna - has spent all the money and plans to leave the cannabis field.Intelicanna also did not make a profit from 2021, during which it presented revenues of only 3.5 million NIS. However, this is an increase compared to revenues of 150,000 NIS during the previous year. In the bottom line, Intelicanna presented a loss of about 15.3 million NIS, which is about 35.4% compared to a loss of approximately 11.3 million NIS last year.IMC - broke an all-time negative Israeli record in an annual loss to a cannabis company.

The long-standing IMC company presented an excellent income of about 138 million NIS in 2021, which is an increase of nearly 241% compared to an income of approximately 40.4 million NIS last year, but the bottom line: the company showed a loss of no less than 94.3 million NIS a year (91.4 million NIS after deducting depreciation on intangible assets), which, as mentioned, is an all-time negative record presented by the cannabis company in the sector.

Revenues then grew, mainly due to acquisitions made by the company of "Panaxia to the house" activity as well as of the pharmacies "Verona" Pharm, "Green" Pharm, and "Oranim" Pharm. But the company continues to disburse money and recently even announced the closure of its cannabis cultivation activity in Israel.